Literature DB >> 25387316

Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.

Mopo Radebe1, Kamini Gounder, Mammekwa Mokgoro, Zaza M Ndhlovu, Zenele Mncube, Lungile Mkhize, Mary van der Stok, Manjeetha Jaggernath, Bruce D Walker, Thumbi Ndung'u.   

Abstract

OBJECTIVE: We characterized protein-specific CD8 T-cell immunodominance patterns during the first year of HIV-1 infection, and their impact on viral evolution and immune control.
METHODS: We analyzed CD8 T-cell responses to the full HIV-1 proteome during the first year of infection in 18 antiretroviral-naïve individuals with acute HIV-1 subtype C infection, all identified prior to seroconversion. Ex-vivo and cultured interferon-γ ELISPOT assays were performed and viruses from plasma were sequenced within defined CTL Gag epitopes.
RESULTS: Nef-specific CD8 T-cell responses were dominant during the first 4 weeks after infection and made up 40% of the total responses at this time; yet, by 1 year, responses against this region had declined and Gag responses made up to 47% of all T-cell responses measured. An inverse correlation between the breadth of Gag-specific responses and viral load set point was evident at 26 weeks after infection (P = 0.0081, r = -0.60) and beyond. An inverse correlation between the number of persistent responses targeting Gag and viral set point was also identified (P = 0.01, r = -0.58). Gag-specific responses detectable by the cultured ELISPOT assay correlated negatively with viral load set point (P = 0.0013, r = -0.91). Sequence evolution in targeted and nontargeted Gag epitopes in this cohort was infrequent.
CONCLUSIONS: These data underscore the importance of HIV-specific CD8 T-cell responses, particularly to the Gag protein, in the maintenance of low viral load levels during primary infection, and show that these responses are initially poorly elicited by natural infection. These data have implications for vaccine design strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387316      PMCID: PMC4427042          DOI: 10.1097/QAD.0000000000000508

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  53 in total

1.  Skewed maturation of memory HIV-specific CD8 T lymphocytes.

Authors:  P Champagne; G S Ogg; A S King; C Knabenhans; K Ellefsen; M Nobile; V Appay; G P Rizzardi; S Fleury; M Lipp; R Förster; S Rowland-Jones; R P Sékaly; A J McMichael; G Pantaleo
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

2.  HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.

Authors:  Mathias Lichterfeld; Xu G Yu; Daniel Cohen; Marylyn M Addo; Jessica Malenfant; Beth Perkins; Eunice Pae; Mary N Johnston; Daryld Strick; Todd M Allen; Eric S Rosenberg; Bette Korber; Bruce D Walker; Marcus Altfeld
Journal:  AIDS       Date:  2004-07-02       Impact factor: 4.177

3.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

Authors:  G Pantaleo; J F Demarest; H Soudeyns; C Graziosi; F Denis; J W Adelsberger; P Borrow; M S Saag; G M Shaw; R P Sekaly
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

6.  Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Authors:  Agatha Masemola; Tumelo Mashishi; Greg Khoury; Phineas Mohube; Pauline Mokgotho; Efthyia Vardas; Mark Colvin; Lynn Zijenah; David Katzenstein; Rosemary Musonda; Susan Allen; Newton Kumwenda; Taha Taha; Glenda Gray; James McIntyre; Salim Abdool Karim; Haynes W Sheppard; Clive M Gray
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point.

Authors:  Wendy A Burgers; Catherine Riou; Mandla Mlotshwa; Pholo Maenetje; Debra de Assis Rosa; Jason Brenchley; Koleka Mlisana; Daniel C Douek; Richard Koup; Mario Roederer; Guy de Bruyn; Salim Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

Authors:  R Draenert; C L Verrill; Y Tang; T M Allen; A G Wurcel; M Boczanowski; A Lechner; A Y Kim; T Suscovich; N V Brown; M M Addo; B D Walker
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.

Authors:  Mathias Lichterfeld; Daniel E Kaufmann; Xu G Yu; Stanley K Mui; Marylyn M Addo; Mary N Johnston; Daniel Cohen; Gregory K Robbins; Eunice Pae; Galit Alter; Alysse Wurcel; David Stone; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  30 in total

1.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.

Authors:  Marilia Rita Pinzone; Erin Graf; Lindsay Lynch; Brigit McLaughlin; Frederick M Hecht; Mark Connors; Stephen A Migueles; Wei-Ting Hwang; Giuseppe Nunnari; Una O'Doherty
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 2.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

3.  Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.

Authors:  Geetha H Mylvaganam; Lynette S Chea; Gregory K Tharp; Sakeenah Hicks; Vijayakumar Velu; Smita S Iyer; Claire Deleage; Jacob D Estes; Steven E Bosinger; Gordon J Freeman; Rafi Ahmed; Rama R Amara
Journal:  JCI Insight       Date:  2018-09-20

4.  Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.

Authors:  Zaza M Ndhlovu; Samuel W Kazer; Thandeka Nkosi; Funsho Ogunshola; Daniel M Muema; Gursev Anmole; Shayda A Swann; Amber Moodley; Krista Dong; Tarylee Reddy; Mark A Brockman; Alex K Shalek; Thumbi Ndung'u; Bruce D Walker
Journal:  Sci Transl Med       Date:  2019-05-22       Impact factor: 17.956

5.  Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.

Authors:  Esper G Kallas; Nicole A Grunenberg; Chenchen Yu; Bryce Manso; Giuseppe Pantaleo; Martin Casapia; Lindsey R Baden; Javier Valencia; Magdalena Sobieszczyk; Hong Van Tieu; Mary Allen; John Hural; Barney S Graham; James Kublin; Peter B Gilbert; Lawrence Corey; Paul A Goepfert; M Juliana McElrath; R Paul Johnson; Yunda Huang; Nicole Frahm
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

6.  In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with less HIV quasispecies diversity.

Authors:  Mark A Pilkinton; Wyatt J McDonnell; Louise Barnett; Abha Chopra; Rama Gangula; Katie D White; Shay Leary; Jennifer Currenti; Silvana Gaudieri; Simon A Mallal; Spyros A Kalams
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

7.  HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.

Authors:  Feng Yun Yue; Jared C Cohen; Mu Ho; A K M Nur-Ur Rahman; Jun Liu; Shariq Mujib; Aamir Saiyed; Sabrina Hundal; Alexandra Khozin; Phil Bonner; Daheng Liu; Erika Benko; Colin Kovacs; Mario Ostrowski
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

8.  Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.

Authors:  Zaza M Ndhlovu; Philomena Kamya; Nikoshia Mewalal; Henrik N Kløverpris; Thandeka Nkosi; Karyn Pretorius; Faatima Laher; Funsho Ogunshola; Denis Chopera; Karthik Shekhar; Musie Ghebremichael; Nasreen Ismail; Amber Moodley; Amna Malik; Alasdair Leslie; Philip J R Goulder; Søren Buus; Arup Chakraborty; Krista Dong; Thumbi Ndung'u; Bruce D Walker
Journal:  Immunity       Date:  2015-09-08       Impact factor: 31.745

9.  Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.

Authors:  Jennifer S Sims; Boris Grinshpun; Yaping Feng; Timothy H Ung; Justin A Neira; Jorge L Samanamud; Peter Canoll; Yufeng Shen; Peter A Sims; Jeffrey N Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-03       Impact factor: 11.205

Review 10.  Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era.

Authors:  Wei Cao; Vikram Mehraj; Daniel E Kaufmann; Taisheng Li; Jean-Pierre Routy
Journal:  J Int AIDS Soc       Date:  2016-03-03       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.